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S318 Poster Session IConclusion:Children and adolescents who undergo RTC appear to
have significantly better PF outcomes one to two years after SCT
versus those undergoingMAC. Development of cGVHD is a signif-
icant predictor of PF deterioration.
Table 1. Pulmonary Function Testing Before and After SCT
Pre-SCT Mean Post-SCT Mean
N (%-predicted) (%-predicted) p-valueFVC 40 85.5±2.4% 77.2±2.6% <0.0001
FEV1 40 88.7±3.0% 79.5±2.9% <0.0001
TLC 26 92.7±3.3% 85.0±3.7% 0.012
DLCO 35 72.6±3.3% 66.0±3.3% 0.033
FEV1/FVC 40 102.8±1.6% 103.1±1.5% 0.837302
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Cancer treatments for hematologic malignancies can include radi-
ation, chemotherapy, immunosuppression, stem cell transplant, and
targeted biological therapies. These therapies can cause long-term
side effects that may negatively affect quality of life. This plan is
most effective when factors such as past treatments, chromosomal
prognostic factors, comorbid health conditions, and lifestyle behav-
iors are considered.
A survivorship care plan specific for cancer survivors who have un-
dergone a hematopoietic stem cell transplant (HSCT) would en-
hance the ability of clinicians to monitor for late effects. The
Center for International Blood and Marrow Transplant Research,
the European Group for Blood and Marrow Transplantation, and
the American Society for Blood and Marrow Transplant have re-
commended that a HSCT-specific survivorship care plan include
6-month, 12-month, and annual assessments of physical and psycho-
social well-being including preventive screenings unique to the
HSCT survivor.
The purpose of this quality improvement study was to describe the
frequency of documentation of the recommended cancer survivor-
ship guidelines by oncology clinicians in the medical records of adult
HSCT survivors at 12 and 24months post-transplant in one compre-
hensive cancer center. This retrospective chart reviewwas conducted
over 2 years. Charts were selected based on length of time since
HSCT. Over 300 charts were included in this study. Only 3 of the
29 recommended guidelines were documented as being completed
in more than 50% of the charts at 12 and 24 months. These 3 indi-
cators included aggressive management of blood pressure, serum
blood urea nitrogen and creatinine and serum liver function testing.
There were 2 additional indicators which were documented as com-
pleted in more than 50% of the charts at 12 months post HSCT, but
less than 50% of the charts at 24 months post HSCT. These indica-
tors were ‘consideration of herpes simplex virus and antifungal pro-
phylaxis’ and ‘pneumocystis carinii pneumonia prophylaxis.’
Additionally, the data indicated that the remaining indicators were
documented in less than 50% of the charts at both 12 and 24months.
These findings were used to inform the oncology clinicians of the
need for adherence to recommended guidelines and in the planning
of a hematology and transplant survivorship clinic for individuals
who have completed the acute phase of their cancer treatment.
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Date of diagnosis Age at diagnosis Date therapy complete
Prognostic features CytogeneticsSummary of treatment:
Treatment Center(s):
Past Medical History
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A SNAPSHOT OF MY LIFE: PHOTOVOICE PHOTOGRAPHY PROJECT
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The Bone Marrow Transplant Unit in the Cancer and Blood Dis-
eases Institute is a place of hope for many patients and families im-
pacted with diseases ranging from cancer, bone marrow failure to
immunology disorders. When most other treatments have failed,
and bone marrow transplant is a viable option, the families will typ-
ically proceed with this treatment. What follows is a prolonged hos-
pitalization with an even greater length of follow-up. The need to
address the patients’ and families’ psychological well-being and cop-
ing strategies becomes a priority during such an extended inpatient
stay, and finding creative ways to do so can be challenging. Through
this concern, A Snapshot of My Life: Photovoice Photography Project was
developed to support patients in processing and sharing their feel-
ings and experiences. Patients, ages five to 23 were loaned digital
cameras to record days in their lives on the BMT unit. During the
review of photos, social workers interacted with the patient to elicit
feelings connected to the photos, creating a therapeutic environment
for the patient and family. This presentation will discuss the Photo-
voice demonstration project on a pediatric bone marrow transplant
unit from inception to implementation. The impact on the patient,
relationship between patient and caregiver, and the influence of
the project on the medical team and therapeutic relationships will
be shared. As a result of the project, a deeper understanding of the
emotional impact a bone marrow transplant and subsequent treat-
ment has on patients was gained. In addition, the therapeutic
